Celgene Corp (NASDAQ:CELG)

92.41
Delayed Data
As of Jun 26
 -0.78 / -0.84%
Today’s Change
58.59
Today|||52-Week Range
98.97
+44.19%
Year-to-Date
The 2 Biggest Casualties From the Celgene-Bristol-Myers Merger (So Far)
Jun 26 / MotleyFool.comFOO - Paid Partner Content
The 10 Biggest Biotech Stocks
Jun 25 / MotleyFool.comFOO - Paid Partner Content
5 Health Care Stocks in Gurus' Portfolios
Jun 26 / GuruFocus NewsGURU - Paid Partner Content
Company News For Jun 25, 2019
Jun 25 / Zacks.comZAK - Paid Partner Content
AbbVie to Acquire Allergan in Nearly $62B Cash & Stock Deal
Jun 26 / Zacks.comZAK - Paid Partner Content
What Happened in the Stock Market Today
Jun 24 / MotleyFool.comFOO - Paid Partner Content
AbbVie + Allergan: Where Are The Synergies?
Jun 25 / Zacks.comZAK - Paid Partner Content
Why These Innovative Biotech ETFs Soaring
Jun 24 / Zacks.comZAK - Paid Partner Content
Bristol-Myers to Sell Otezla for Celgene Merger, Shares Down
Jun 25 / Zacks.comZAK - Paid Partner Content
Wall Street Mostly Lower Monday
Jun 24 / GuruFocus NewsGURU - Paid Partner Content

Today’s Trading

Previous close93.19
Today’s open93.56
Day’s range92.01 - 93.75
Volume5,225,330
Average volume (3 months)7,633,573
Market cap--
Data as of 4:15pm ET, 06/26/2019

Growth & Valuation

Earnings growth (last year)+49.83%
Earnings growth (this year)+21.11%
Earnings growth (next 5 years)+14.80%
Revenue growth (last year)+19.26%
P/E ratio14.1
Price/Sales3.08
Price/Book--

Competitors

 Today’s
change
Today’s
% change
BMYBristol-Myers Squibb-0.85-1.86%
TAKTakeda Pharmaceutica...+0.10+0.57%
ZTSZoetis Inc-0.81-0.71%
AGNAllergan+1.57+0.97%
Data as of 4:02pm ET, 06/26/2019

Financials

Next reporting dateJuly 29, 2019
EPS forecast (this quarter)$2.62
Annual revenue (last year)$15.3B
Annual profit (last year)$4.0B
Net profit margin26.46%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President, CEO &
COO
Mark J. Alles
CFO, Principal Accounting Officer &
Executive VP
David V. Elkins
Corporate headquarters
Summit, New Jersey

Forecasts